Title: Integrating Genomic Testing into Oncology Practice

Date: July 5, 2025

Genomic testing is no longer a luxury—it's quickly becoming a standard in modern oncology care. With the rise of precision medicine, understanding the molecular landscape of a patient’s tumor can drastically alter therapeutic decisions and improve outcomes.

At Atlas Oncology Partners, we’ve worked with hundreds of practices to incorporate genomic panels into diagnostic routines. It begins with knowing when to test. For certain cancers like non-small cell lung cancer, breast cancer, and colorectal cancer, genomic insights can determine eligibility for targeted therapies or immunotherapies.

One of the biggest challenges providers face is workflow integration. We recommend working closely with your pathology and molecular labs to ensure timely results. Establish EMR triggers for genomic test ordering and results flagging. Educate your staff and patients alike—many still don’t understand why this testing matters.

Reimbursement remains a barrier in some settings, but payer coverage is improving, especially when tests are guideline-recommended. Our partner toolkit includes scripts for prior authorizations, patient handouts, and recommended vendors.

Genomic testing isn’t just about technology—it’s about offering more accurate, personalized hope. As oncology evolves, staying ahead of these tools is not optional—it’s essential.